• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SARS-CoV-2 Transmission and Outcome in Neuro-rehabilitation Patients Hospitalized at Neuroscience Hospital in Italy.

作者信息

Di Gennaro Francesco, Marotta Claudia, Storto Marianna, D'Avanzo Carmine, Foschini Nunzia, Maffei Luigi, de Gaetano Giovanni, Centonze Diego, Iezzi Ennio

机构信息

IRCCS Istituto Neurologico Mediterraneo NEUROMED, 86077 Pozzilli, Italy.

Unit of Neurology and Neurorehabilitation, IRCCS Neuromed, Pozzilli (IS), Italy.

出版信息

Mediterr J Hematol Infect Dis. 2020 Sep 1;12(1):e2020063. doi: 10.4084/MJHID.2020.063. eCollection 2020.

DOI:10.4084/MJHID.2020.063
PMID:32952974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7485473/
Abstract
摘要

相似文献

1
SARS-CoV-2 Transmission and Outcome in Neuro-rehabilitation Patients Hospitalized at Neuroscience Hospital in Italy.意大利神经科学医院住院神经康复患者中新冠病毒 2 的传播与转归
Mediterr J Hematol Infect Dis. 2020 Sep 1;12(1):e2020063. doi: 10.4084/MJHID.2020.063. eCollection 2020.
2
Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients.新型冠状病毒肺炎的神经系统症状：一项针对住院患者的横断面单中心研究
Neurol Res Pract. 2021 Mar 12;3(1):17. doi: 10.1186/s42466-021-00116-1.
3
Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection.新冠病毒感染住院患者及新冠病毒感染后急性后遗症患者神经病理发生的血浆生物标志物
Neurol Neuroimmunol Neuroinflamm. 2022 Mar 7;9(3). doi: 10.1212/NXI.0000000000001151. Print 2022 May.
4
Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.重症监护治疗新型冠状病毒 SARS-CoV-2 感染患者：意大利克雷马医院的经验。
Am J Emerg Med. 2021 Jul;45:156-161. doi: 10.1016/j.ajem.2020.08.005. Epub 2020 Aug 16.
5
Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study.使用依诺肝素进行血栓预防与感染SARS-CoV-2的住院患者较低的死亡率相关。一项队列研究。
EClinicalMedicine. 2020 Oct 5;27:100562. doi: 10.1016/j.eclinm.2020.100562. eCollection 2020 Oct.
6
Enoxaparin Use in Hospitalized SARS-CoV-2-Positive Patients with Elevated D-Dimer: A Pilot Study.依诺肝素在住院的D-二聚体升高的新冠病毒阳性患者中的应用：一项初步研究。
J Pharm Pract. 2023 Jun;36(3):532-536. doi: 10.1177/08971900211064184. Epub 2021 Dec 24.
7
[Neurological aspects of the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus].[由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引起的2019冠状病毒病大流行的神经学方面]
Ideggyogy Sz. 2020 May 30;73(05-06):171-175. doi: 10.18071/isz.73.0171.
8
SARS-CoV-2 Infection in Children in Southern Italy: A Descriptive Case Series.意大利南部儿童中 SARS-CoV-2 感染：一项描述性病例系列研究。
Int J Environ Res Public Health. 2020 Aug 21;17(17):6080. doi: 10.3390/ijerph17176080.
9
Clinical course of SARS-CoV-2 infection in patients with severe acquired brain injury and a disorder of consciousness: an observational study.严重获得性脑损伤和意识障碍患者感染新型冠状病毒2的临床病程：一项观察性研究
Brain Inj. 2021 Apr 16;35(5):520-529. doi: 10.1080/02699052.2021.1887937. Epub 2021 Feb 15.
10
Self-Reported Symptoms of SARS-CoV-2 Infection in a Nonhospitalized Population in Italy: Cross-Sectional Study of the EPICOVID19 Web-Based Survey.意大利非住院人群中 SARS-CoV-2 感染的自我报告症状：基于 EPICOVID19 网络调查的横断面研究。
JMIR Public Health Surveill. 2020 Sep 18;6(3):e21866. doi: 10.2196/21866.

引用本文的文献

1
Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence.新型冠状病毒肺炎与凝血障碍的相互关系：病理生理学和临床证据。
Int J Mol Sci. 2023 May 18;24(10):8945. doi: 10.3390/ijms24108945.
2
The Outcomes of COVID-19 Patients with Spontaneous Intracerebral Hemorrhage Comorbidity and the Efficacy of Enoxaparin in Decreasing the Mortality Rate in Them: Single Egyptian Center Report.新型冠状病毒肺炎合并自发性脑出血患者的预后及依诺肝素降低其死亡率的疗效：埃及单中心报告
J Pers Med. 2022 Nov 2;12(11):1822. doi: 10.3390/jpm12111822.
3
New endemic and pandemic pathologies with interhuman airborne transmission through ear, nose and throat anatomical sites.通过耳、鼻、喉解剖部位在人际间空气传播的新型地方性和大流行性疾病。
Acta Otorhinolaryngol Ital. 2022 Apr;42(Suppl. 1):S5-S13. doi: 10.14639/0392-100X-suppl.1-42-2022-01.
4
Potential Adverse Effects of Dexamethasone Therapy on COVID-19 Patients: Review and Recommendations.地塞米松治疗对COVID-19患者的潜在不良影响：综述与建议
Infect Dis Ther. 2021 Dec;10(4):1907-1931. doi: 10.1007/s40121-021-00500-z. Epub 2021 Jul 22.
5
Epidemiology, Clinical Characteristics, and Outcomes of a Large Cohort of COVID-19 Outpatients in Michigan.密歇根州大量新冠门诊患者队列的流行病学、临床特征及转归
Int J Gen Med. 2021 Apr 28;14:1555-1563. doi: 10.2147/IJGM.S305295. eCollection 2021.
6
First and second waves of coronavirus disease-19: A comparative study in hospitalized patients in Reus, Spain.新冠肺炎疫情的第一波和第二波：西班牙雷乌斯住院患者的对比研究。
PLoS One. 2021 Mar 31;16(3):e0248029. doi: 10.1371/journal.pone.0248029. eCollection 2021.

本文引用的文献

1
Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.肝素和依诺肝素衍生物对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）进入的有效抑制作用
J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.01987-20.
2
Spontaneous and Severe Haematomas in Patients with COVID-19 on Low- Molecular-Weight Heparin for Paroxysmal Atrial Fibrillation.新型冠状病毒肺炎患者因阵发性心房颤动接受低分子量肝素治疗时出现的自发性严重血肿
Mediterr J Hematol Infect Dis. 2020 Jul 1;12(1):e2020054. doi: 10.4084/MJHID.2020.054. eCollection 2020.
3
Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review.冠状病毒病（COVID-19）的现状和未来展望：叙事性综述。
Int J Environ Res Public Health. 2020 Apr 14;17(8):2690. doi: 10.3390/ijerph17082690.
4
[Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia].7例危重型新型冠状病毒肺炎合并肢端缺血患者的临床及凝血特征
Zhonghua Xue Ye Xue Za Zhi. 2020 Mar 28;41(0):E006. doi: 10.3760/cma.j.issn.0253-2727.2020.0006.
5
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
6
Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020.2020 年 1 月至 2 月期间，中国武汉一家医院对 4880 例病例进行的 SARS-CoV-2 感染的 RT-PCR 检测阳性率。
Clin Chim Acta. 2020 Jun;505:172-175. doi: 10.1016/j.cca.2020.03.009. Epub 2020 Mar 7.
7
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics.血管紧张素受体阻滞剂可作为治疗 SARS-CoV-2 的候选药物。
Drug Dev Res. 2020 Aug;81(5):537-540. doi: 10.1002/ddr.21656. Epub 2020 Mar 4.
8
Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases.中国 2019 年冠状病毒病（COVID-19）的胸部 CT 与 RT-PCR 检测的相关性：1014 例报告。
Radiology. 2020 Aug;296(2):E32-E40. doi: 10.1148/radiol.2020200642. Epub 2020 Feb 26.
9
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
10
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.